Global Point-of-care Glucose Testing Market

Point-of-care Glucose Testing Market Size, Share, Growth Analysis, By Prescription(OTC testing, and Prescription-based testing), By End-use(Hospitals, Diagnostic centers, Research laboratories, Home-care settings), By Region - Industry Forecast 2024-2031


Report ID: SQMIG15E2398 | Region: Global | Published Date: March, 2024
Pages: 184 | Tables: 64 | Figures: 75

Point-of-care Glucose Testing Market Dynamics

Point-of-care Glucose Testing Market Drivers

Rising Diabetes Prevalence

  • The increasing global incidence of diabetes is a major driver of the point-of-care glucose testing market. According to the International Diabetes Federation, the number of adults living with diabetes is expected to reach 700 million by 2045. This surge in diabetes cases necessitates regular glucose monitoring, leading to a higher demand for point-of-care testing devices.

Technological Advancements

  • Continuous technological advancements in glucose testing devices are driving market growth. Innovations such as wireless connectivity, smartphone integration, and cloud-based data management systems are enhancing the functionality and usability of point-of-care glucose testing devices. These advancements enable seamless data sharing, remote monitoring, and real-time insights for both healthcare professionals and patients.

Point-of-care Glucose Testing Market Restraints

Cost Constraints

  • The cost of point-of-care glucose testing devices and consumables can be a restraining factor for market growth. Affordability remains a challenge, particularly in developing regions with limited healthcare resources and lower disposable incomes. The high cost of these devices may hinder their widespread adoption, particularly among low-income individuals and healthcare facilities with budget constraints.

Regulatory Challenges

  • The point-of-care glucose testing market is subject to regulatory requirements and quality control standards to ensure the accuracy and reliability of the devices. Compliance with these regulations can be complex and time-consuming, posing challenges for market players. Stringent regulatory processes and variations in approval timelines across different regions can slow down product launches and hinder market growth.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Point-of-Care glucose testing Market size was valued at USD 3.3 billion in 2022 and is poised to grow from USD 3.44 billion in 2023 to USD 4.78 billion by 2031, at a CAGR of 4.2% during the forecast period (2024-2031).

The point-of-care glucose testing market is a highly competitive landscape with the presence of several key players. These companies strive to maintain their market position by focusing on product innovation, strategic partnerships, and geographical expansion. Key players in the competitive landscape of the point-of-care glucose testing market continuously strive to introduce advanced technologies, improve product efficacy, and enhance user experience. They also engage in strategic partnerships, mergers, and acquisitions to strengthen their market position and expand their geographical presence. With a focus on innovation and customer-centric approaches, these companies contribute significantly to the growth and development of the point-of-care glucose testing market. 'Abbott (US)', 'Dexcom (US)', 'Roche (Switzerland)', 'Ascensia Diabetes Care (Switzerland)', 'LifeScan (US)', 'Medtronic (US)', 'Ypsomed (Switzerland)', 'Animas (US)', 'Insulet (US)', 'Bayer (Germany)', 'Nipro (Japan)', 'Terumo (Japan)', 'Arkray (Japan)', 'Acon Laboratories (US)', 'Freestyle (US)', 'One Touch (US)', 'Accu-Chek (Germany)', 'Dario (US)', 'iHealth (China)', 'FreeStyle Libre (UK)'

The increasing incidence of diabetes is a major driver of the point-of-care glucose testing market. According to the International Diabetes Federation, the number of adults living with diabetes is expected to reach 700 million by 2045. This surge in diabetes cases necessitates regular glucose monitoring, leading to a higher demand for point-of-care testing devices.

Integration with Digital Health Platforms: The integration of point-of-care glucose testing devices with digital health platforms and electronic health records is a significant trend in 2022. This integration enables seamless data transfer, analysis, and real-time monitoring of glucose levels. It empowers patients to actively participate in their diabetes management and allows healthcare professionals to make informed treatment decisions based on comprehensive patient data.

North America holds the largest market share in the point-of-care glucose testing market. This dominance can be attributed to several factors, including the high prevalence of diabetes in the region, well-established healthcare infrastructure, and favorable reimbursement policies. The presence of key market players, technological advancements, and the adoption of innovative glucose testing devices contribute to the region's leadership position. Additionally, increasing awareness among healthcare professionals and patients about the benefits of point-of-care glucose testing drives market growth in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Point-of-care Glucose Testing Market

Report ID: SQMIG15E2398

$5,300
BUY NOW GET FREE SAMPLE